Search research articles
Contact Us
Filters
Showing results (1-10 of 222) with videos related to
Page
of 23
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 6, 2020
Neurofilament light chain as biomarker for axonal damage in Guillain-Barré syndrome
Bart C Jacobs
Nature Reviews. Neurology
|
November 6, 2009
Peripheral neuropathies: Biomarkers for axonal damage in immune-mediated neuropathy
Bart C Jacobs, Hugh J Willison
Brain : a Journal of Neurology
|
May 29, 2016
Neuronal endocytosis of anti-ganglioside antibodies: implications for Guillain-Barré syndrome
Pieter A van Doorn, Bart C Jacobs
Current Opinion in Neurology
|
August 1, 2025
New insights in the immune treatment of Guillain-Barré syndrome
Eveline J A Wiegers, Bart C Jacobs
JAMA Neurology
|
May 16, 2017
Could Albumin be a Biomarker to Monitor the Effect of Intravenous Immunoglobulin on Guillain-Barré Syndrome?-Reply
Willem-Jan R Fokkink, Bart C Jacobs
The Lancet. Neurology
|
November 18, 2006
Predicting the course of Guillain-Barré syndrome
Pieter A van Doorn, Bart C Jacobs
Handbook of Clinical Neurology
|
January 12, 2026
Immunotherapies on Guillain-Barré syndrome and other acute autoimmune neuropathies
Linda W G Luijten, Bart C Jacobs
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 29, 2020
Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic
Antonino Uncini, Jean-Michel Vallat, Bart C Jacobs
The Lancet. Neurology
|
July 19, 2025
When children diagnosed with Guillain-Barré syndrome do not recover
Marie-Claire Y de Wit, Bart C Jacobs
Journal of Neurology, Neurosurgery, and Psychiatry
|
December 30, 2020
Antiglycolipid antibodies in Guillain-Barré and Fisher syndromes: discovery, current status and future perspective
Susumu Kusunoki, Hugh J Willison, Bart C Jacobs
Page
of 23
Search research articles
Search
Showing results (1-10 of 222) with videos related to
Sort By:
Page
of 23
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 6, 2020
Neurofilament light chain as biomarker for axonal damage in Guillain-Barré syndrome
Bart C Jacobs
Nature Reviews. Neurology
|
November 6, 2009
Peripheral neuropathies: Biomarkers for axonal damage in immune-mediated neuropathy
Bart C Jacobs, Hugh J Willison
Brain : a Journal of Neurology
|
May 29, 2016
Neuronal endocytosis of anti-ganglioside antibodies: implications for Guillain-Barré syndrome
Pieter A van Doorn, Bart C Jacobs
Current Opinion in Neurology
|
August 1, 2025
New insights in the immune treatment of Guillain-Barré syndrome
Eveline J A Wiegers, Bart C Jacobs
JAMA Neurology
|
May 16, 2017
Could Albumin be a Biomarker to Monitor the Effect of Intravenous Immunoglobulin on Guillain-Barré Syndrome?-Reply
Willem-Jan R Fokkink, Bart C Jacobs
The Lancet. Neurology
|
November 18, 2006
Predicting the course of Guillain-Barré syndrome
Pieter A van Doorn, Bart C Jacobs
Handbook of Clinical Neurology
|
January 12, 2026
Immunotherapies on Guillain-Barré syndrome and other acute autoimmune neuropathies
Linda W G Luijten, Bart C Jacobs
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 29, 2020
Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic
Antonino Uncini, Jean-Michel Vallat, Bart C Jacobs
The Lancet. Neurology
|
July 19, 2025
When children diagnosed with Guillain-Barré syndrome do not recover
Marie-Claire Y de Wit, Bart C Jacobs
Journal of Neurology, Neurosurgery, and Psychiatry
|
December 30, 2020
Antiglycolipid antibodies in Guillain-Barré and Fisher syndromes: discovery, current status and future perspective
Susumu Kusunoki, Hugh J Willison, Bart C Jacobs
Page
of 23